Upcoming Webinar: 4/28/2021, 12 p.m. Eastern Time (U.S.)

Transcranial magnetic stimulation is among the first therapeutic interventions aimed at addressing some of the symptoms of autism.  Why use TMS? What are its limitations, and what have been its side effects?  Tune in to hear Manuel Casanova, MD, answer these questions and describe the future of this therapeutic intervention.

This webinar is offered in joint-providership by the Autism Research Institute and the World Autism Organization. Free certificates of participation will be available upon successful completion of a brief knowledge quiz after the webinar.

TMS Research Updates 2021

About the speaker:

Manuel Casanova

Manuel Casanova, MD, served on the founding board of the National Alliance for Autism Research (now Autism Speaks) and the Autism Tissue Board. He has served on the Board of Directors or Scientific Advisory Board of numerous organizations including the Autism Research Institute. His research has been recognized by a EUREKA award from the NIMH for the introduction of repetitive Transcranial Magnetic Stimulation (rTMS) in the therapy of autism spectrum disorders.

Biomedical/Epigenetic approach to targeting treatments for autism and neurodevelopmental disorders

February 26th, 2014|Health, Immune Issues, Webinar|

Handouts are available online at: http://www.ariconference.com/webinars/hendren.pdf Certificates of participation are available upon successful completion of a brief knowledge quiz: http://www.classmarker.com/online-test/start/?quiz=hav530dfdd9ca1a3 Robert L. Hendren, D.O., is Professor of Psychiatry and Behavioral Science; Director of